Judith Alvarez-Borillo
Research Subjects
Judith Alvarez-Borillo has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Alba Melià
Unitat de Recerca en Lípids i Arteriosclerosi, Departament de Medicina i Cirurgia, Universitat Rovira i Virgili Reus, 43003 Tarragona, Spain
1 shared publication - Ana Goñi- Navarro
Hospital Clínico Universitario Lozano Blesa
1 shared publication - Antoni Castro
Autoimmunity, Infection and Thrombosis Research Group (GRAIIT), Department of Internal Medicine, Hospital Universitari de Sant Joan, Institut de Recerca Biomèdica Catalunya Sud, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain
1 shared publication - Clara Balsells
Unitat de Recerca en Lípids i Arteriosclerosi, Departament de Medicina i Cirurgia, Universitat Rovira i Virgili Reus, 43003 Tarragona, Spain
1 shared publication Eva Gracia-Peligero
Salud Mental. Hospital Clínico Universitario Lozano Blesa. Servicio Aragonés de Salud. Zaragoza
1 shared publication- Gemma Castillejo
Paediatric Gastroenterology Unit, Hospital Universitario Sant Joan de Reus, Reus, Spain
1 shared publication
Latest Publications
- Open Access
- 30 November 2022
- Published by Asociacion Espanola de Psiquiatria del Nino y del Adolescente - Aepnya in Revista de Psiquiatría Infanto-Juvenil
- Vol. 39 (4) , 42-45
Adolescente prehuntington
The case of an adolescent referred to the Huntington's Unit for psychiatric assessment is selected. Objectives: To make a differential diagnosis between the symptoms of juvenile Huntington's disease (JHD) and the usual behaviors of an adolescent. To present the complexity of the dividing line between neurological and psychiatric disease. To detail the clinical-epidemiological profile of the patients seen in the Functional Huntington's Disease Unit of reference. Se presenta el caso de un adolescente derivado a la Unidad de Huntington para valoración psiquiátrica. Objetivos: Realizar diagnóstico diferencial entre la sintomatología de la enfermedad de Huntington juvenil (EHJ) y las conductas propias de un adolescente; Presentar la complejidad de la línea de separación entre la enfermedad neurológica y psiquiátrica; Detallar el perfil clínico-epidemiológico de los pacientes atendidos en la Unidad Funcional de Enfermedad de Huntington de referencia.
- 30 November 2022
- Published by Asociacion Espanola de Psiquiatria del Nino y del Adolescente - Aepnya in Revista de Psiquiatría Infanto-Juvenil
- Vol. 39 (4) , 42-45
Open AccessAdolescente prehuntington
The case of an adolescent referred to the Huntington's Unit for psychiatric assessment is selected. Objectives: To make a differential diagnosis between the symptoms of juvenile Huntington's disease (JHD) and the usual behaviors of an adolescent. To present the complexity of the dividing line between neurological and psychiatric disease. To detail the clinical-epidemiological profile of the patients seen in the Functional Huntington's Disease Unit of reference. Se presenta el caso de un adolescente derivado a la Unidad de Huntington para valoración psiquiátrica. Objetivos: Realizar diagnóstico diferencial entre la sintomatología de la enfermedad de Huntington juvenil (EHJ) y las conductas propias de un adolescente; Presentar la complejidad de la línea de separación entre la enfermedad neurológica y psiquiátrica; Detallar el perfil clínico-epidemiológico de los pacientes atendidos en la Unidad Funcional de Enfermedad de Huntington de referencia.
- Open Access
- 29 December 2021
- Published by MDPI AG in Biomolecules
- Vol. 12 (1) , 47
Characterization of the LPS and 3OHFA Contents in the Lipoprotein Fractions and Lipoprotein Particles of Healthy Men
Atherosclerosis is a chronic inflammatory disease that is caused by the accumulation of LDL particles in the intima, causing the activation of immune cells and triggering an inflammatory response. LPS is a potent activator of the innate immune response and it can be transported by lipoproteins. Since humans are much more sensitive to LPS than other mammals, and very low amounts of LPS can elicit an immune response, the aim of this study is to characterize the distribution of LPS and its immunogenic portion (3OHFAs) among lipoprotein types of healthy men. We separated lipoprotein fractions by ultracentrifugation and the amount of each 3OHFA was measured by MS in each lipoprotein fraction to calculate LPS concentration. Lipoprotein particle concentration was measured by NMR. LDL and HDL fractions transported the highest concentration of LPS (35.7% and 31.5%, respectively), but VLDL particles carried more LPS molecules per particle (0.55 molecules/particle) than LDL or HDL (p < 0.01). The distribution of LPS and all 3OHFAs among lipoprotein fractions showed high interindividual variability, suggesting that they may be studied as a potential biomarker. This may help understand the role of LPS in atherosclerosis in those cases where the disease cannot be explained by traditional risk factors.
- 29 December 2021
- Published by MDPI AG in Biomolecules
- Vol. 12 (1) , 47
Open AccessCharacterization of the LPS and 3OHFA Contents in the Lipoprotein Fractions and Lipoprotein Particles of Healthy Men
Atherosclerosis is a chronic inflammatory disease that is caused by the accumulation of LDL particles in the intima, causing the activation of immune cells and triggering an inflammatory response. LPS is a potent activator of the innate immune response and it can be transported by lipoproteins. Since humans are much more sensitive to LPS than other mammals, and very low amounts of LPS can elicit an immune response, the aim of this study is to characterize the distribution of LPS and its immunogenic portion (3OHFAs) among lipoprotein types of healthy men. We separated lipoprotein fractions by ultracentrifugation and the amount of each 3OHFA was measured by MS in each lipoprotein fraction to calculate LPS concentration. Lipoprotein particle concentration was measured by NMR. LDL and HDL fractions transported the highest concentration of LPS (35.7% and 31.5%, respectively), but VLDL particles carried more LPS molecules per particle (0.55 molecules/particle) than LDL or HDL (p < 0.01). The distribution of LPS and all 3OHFAs among lipoprotein fractions showed high interindividual variability, suggesting that they may be studied as a potential biomarker. This may help understand the role of LPS in atherosclerosis in those cases where the disease cannot be explained by traditional risk factors.